Stay updated with breaking news from Par Value. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eine in den 30er Jahren geprägte Münze ist das teuerste Geldstück der Welt: Die 'Double Eagle'-Münzen wurden von US-Behörden beschlagnahmt. Diese eine jedoch befand sich in der Sammlung des ägyptischen Königs.
DASSAULT SYSTEMES FIVE-FOR-ONE STOCK SPLIT ON JULY 7, 2021 Vélizy-Villacoublay, France, May 27, 2021 – Dassault Systèmes (Euronext Paris: #13065, DSY.PA) announces that the General Meeting of Shareholders held on May 26, 2021 decided to split the par value of the Dassault Systèmes’ share by five. This decision follows the increase in the share price from €73.77 to €166.15 between December 31, 2015 and December 31, 2020 (i.e. an increase of 125%). Bernard Charles, Dassault Systèmes’ Vice chairman and Chief Executive Officer, commented: ...
Pratteln, Schweiz, 27. Mai 2021 - Santhera Pharmaceuticals (SIX: SANN) gibt die Einladung zur ordentlichen Generalversammlung (GV) bekannt, die am 22. Juni 2021 um 10:30 Uhr am Sitz der Gesellschaft stattfinden
Press release content from Business Wire. The AP news staff was not involved in its creation. Northern Oil and Gas, Inc. Announces First Quarter 2021 Results May 7, 2021 GMT MINNEAPOLIS--(BUSINESS WIRE)--May 7, 2021-- Northern Oil and Gas, Inc. (NYSE American: NOG) (“Northern”) today announced the company’s first quarter results. MANAGEMENT COMMENTS “The first quarter performance was above our internal expectations across all metrics as our core Williston & Permian properties continued to deliver,” commented Nick O’Grady, Northern’s Chief Executive Officer. “The Company genera...
Lantern Pharma Reports First Quarter 2021 Financial Results and Operational Highlights - RADR® A.I. platform surpasses 4.6 billion datapoints curated for oncology drug development across a wide a range of tumors and drug classes - Phase 2 clinical trial for non-smokers with NSCLC (Non-Small Cell Lung Cancer) utilizing LP-300 in combination with chemotherapy scheduled to begin during third quarter of 2021 - Expanded potential indications for LP-184 to include ATRT pediatric brain cancers - Initiated preclinical development of new molecular entity, LP-284, in hematologic cancers - Strengthened...